With the holidays now behind us and carnival days looming ahead, Cypriots love a night out, even if it means consuming enormous amounts of alcohol and regretting it the next morning.Ready to solve ...

“Southern Hospitality” star Grace Lilly was arrested after cops found “happy pills” in her car, Page Six can exclusively reveal. The 27-year-old was arrested by the Charleston Police Department and ...

Severe stomach pain can signal acute mesenteric ischemia, a deadly sudden loss of intestinal blood flow. Donald Trump threatens to terminate broadcast licenses of major networks Heroic survivor ...

Novo Nordisk (NYSE:NVO), which develops and markets diabetes and obesity treatments, closed Tuesday’s session at $51.61, up 7.30% after U.S. approval of its once-daily oral Wegovy weight-loss pill.

Novo Nordisk first to market with Wegovy pill Analysts see potential but question if pills are a 'game changer' Advantage for Novo could be short-lived, analysts say The approval of Novo's Wegovy pill ...

Novo Nordisk A/S (NYSE: NVO) shares are trading higher Tuesday following FDA approval of its Wegovy pill. Novo Nordisk stock is among today’s top performers. Why is NVO stock up today? What To Know: ...

Dec 23 (Reuters) - Novo Nordisk shares jumped ‌10% on Tuesday after the U.S. Food and ‌Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival Eli ...

Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in ...

Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...

FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo Dec 18 (Reuters) - Eli Lilly's oral pill, ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...